CHV (Catalyst Health Ventures) invests in transformative MedTech companies that are addressing global unmet healthcare needs and have the potential to become the new standard of care. Our thesis is exclusively focused on innovative early stage therapeutic devices, diagnostics and digital health solutions that significantly improve outcomes for patients, providers and payers.